Non-acidic NSAID prodrug
Nabumetone
Brand names: Relifex
Adult dose
Dose: 1g at night, increase to 1g at night + 0.5–1g morning if needed
Route: PO
Frequency: OD-BD
Clinical pearls
- OA, RA
- Lower acute GI risk than non-selective NSAIDs (still significant)
Contraindications
- Active GI bleeding/ulcer
- Severe heart failure
- Severe renal/hepatic impairment
- Aspirin/NSAID hypersensitivity
- 3rd trimester pregnancy
Side effects
- GI upset/bleeding
- Renal impairment
- Cardiovascular events
- Headache
Interactions
- Anticoagulants/antiplatelets
- ACEi/ARB
- Lithium
- Methotrexate
Reference: BNF; NICE NG100; https://bnf.nice.org.uk/drugs/nabumetone/. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Pathways
- Cutaneous Lupus Erythematosus · BAD; EULAR
- Osteoporosis / Fragility Fracture · NOGG 2021; NICE NG147; NG224
- Arteritic AION (Giant Cell Arteritis) · RCOphth; BSR
- Osteoarthritis Hip / Knee Management · NICE NG226 (2022)
- Lupus Nephritis · EULAR/ERA-EDTA 2019; KDIGO 2024
- Rheumatoid Arthritis Management · NICE CG79 2018 / EULAR 2022